Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vivesto Major Shareholding Notification 2013

Jan 15, 2013

3124_rns_2013-01-15_7be428b7-6651-4c31-b228-986d87bf189f.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

2013-01-15

PRESS RELEASE

Nexttobeincreases their ownershipin Oasmia

The investment companyNexttobe AB, with the entrepreneurBengt €gerup at the helm, hasincreased their shareholding in Oasmia Pharmaceutical ABwith 3 432791shares and now holds 21.6 % of the shares and votes in Oasmia. The companyis Oasmia•s second largest owner.

  • That Nexttobe increases t heir shareholding in Oasmia is very positive in our viewsince it means that they see the potential in our products and demonstrates a large confidence in our company. We see Nexttobe as a long -term partner and they offer considerable support for us in our business, says Julian Aleksov, CEO of Oasmia.

For more information contact: Johan Edin, Acting Head of Public Relations, Oasmia Pharmaceutical AB. E -mail: [email protected]m. Tel: +46 (0)18' 50 54 40. More information is available on www.nasdaqomxnordic.com, www.boerse -frankfurt.de andwww.oasmia.com

€Oasmia is required under the Financial Instruments Trading Act to make the information in this press release public. The information was submittedfor publicationat 10.30a.m. CET onJanuray15.•